Grocer Albertsons priced its initial public offering at $16 a share—raising less than planned, a source said—in the first major initial offering since the New York Stock Exchange trading floor reopened
Albertsons Cos. priced its initial public offering below expectations and its existing shareholders sold fewer shares than planned, marking a stumble for the IPO market after it had been revived by a string of strong offerings.
Albertsons’ IPO priced at $16 a share, according to people familiar with the matter, and raised $800 million through the sale of 50 million shares. It had planned for existing shareholders to sell 65.8 million shares at $18 to $20 a share, according to a regulatory filing.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Insurance startup Lemonade takes valuation hit in IPO price range - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
Palantir appoints first female board member ahead of IPOSilicon Valley data miner Palantir has appointed Wall Street Journal reporter Alexandra Wolfe Schiff to its board.
Read more »
Albertsons stock is worth buying at $25 after it IPOs Thursday, Jim Cramer says'It's definitely not best of breed, but it's not garbage either,' the 'Mad Money' host said.
Read more »
WSJ News Exclusive | Disney Weighs Postponing July 24 Release of ‘Mulan’ as Theaters Struggle to ReopenWalt Disney is considering postponing the July 24 release of “Mulan,” according to a person familiar with the matter, a rescheduling that could call into question hopes across Hollywood and the movie-theater industry to have cinemas up and running next month.
Read more »
WSJ News Exclusive | Shorter-Term Health Plans Force Many to Pay for Lifesaving Treatments, Report FindsMany consumers have been forced to pay for their own lifesaving treatment under shorter-term health plans that have seen enrollment jumps since the Trump administration relaxed restrictions on them, according to a new report by House Democrats.
Read more »